ProductsDistribution Products

LAMZEDE

Therapeutic indication:

Enzyme replacement therapy for the treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis.

  • Composition: Velmanase Alfa 10 mg/vial
  • Pharmaceutical form: Powder for solution for infusion, white to off-white powder
  • Method of administration: Intravenous infusion
  • Manufacturer: Chiesi
LAMZEDE - Product Logo
LAMZEDE - Product Image

Join Our Mailing List

Sign up to receive Email updates from Kamada

Latest News

Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance
Nov. 13, 2024